Medicare spending analysis for Cardiology providers
Cardiology accounts for $34.8B in Medicare payments across 180.3K providers.
The specialty's average markup of 3.6x is below the overall Medicare average of 3.77x.
AI-generated analysis based on Medicare payment data.
| Year | Payments | Services | Providers | YoY Change |
|---|---|---|---|---|
| 2014 | $4.6B | 85.8M | 22.6K | — |
| 2015 | $4.2B | 76.7M | 20.7K | -9.4% |
| 2017 | $4.0B | 72.1M | 20.3K | -4.2% |
| 2018 | $3.9B | 69.7M | 19.7K | -2.5% |
| 2019 | $4.0B | 68.2M | 19.7K | +1.2% |
| 2020 | $3.4B | 57.3M | 19.4K | -15.2% |
| 2021 | $3.7B | 59.5M | 19.3K | +9.4% |
| 2022 | $3.5B | 57.3M | 19.3K | -5.6% |
| 2023 | $3.5B | 57.8M | 19.4K | +0.1% |
| # | Provider | State | Payments | Services | Avg/Service |
|---|---|---|---|---|---|
| 1 | Mehran Khorsandi | CA | $6.1M | 22.6K | $267.81 |
| 2 | Leo Polosajian | CA | $6.0M | 33.2K | $181.95 |
| 3 | Victor Gabrielian | CA | $5.0M | 18.7K | $266.87 |
| 4 | Afshine Emrani | CA | $5.0M | 226.1K | $22.11 |
| 5 | Vikram Lakireddy | CA | $4.8M | 33.5K | $143.51 |
| 6 | Inder Singh | CA | $4.7M | 6.1K | $777.43 |
| 7 | James Joye | CA | $4.5M | 12.3K | $366.74 |
| 8 | Athar Ansari | CA | $4.4M | 42.9K | $102.24 |
| 9 | Salvador Borromeo | NV | $4.3M | 12.2K | $353.85 |
| 10 | Sam Kalioundji | CA | $4.1M | 37.8K | $109.11 |
| 11 | Hanumandla Reddy | CA | $3.8M | 17.7K | $214.71 |
| 12 | Shashi Sharma | CA | $3.6M | 13.9K | $260.29 |
| 13 | Rajiv Agarwal | TX | $3.3M | 50.0K | $65.17 |
| 14 | Nallathamby Thayapran | CA | $3.2M | 11.6K | $279.12 |
| 15 | Saman Fakheri | CA | $3.2M | 18.6K | $170.91 |
| 16 | Mehran Moussavian | CA | $3.0M | 14.6K | $204.14 |
| 17 | Pareena Bilkoo | FL | $2.9M | 83.2K | $35.11 |
| 18 | Karthik Gujja | NY | $2.9M | 3.8K | $757.77 |
| 19 | Naveen Sharma | CA | $2.9M | 8.1K | $350.95 |
| 20 | Joseph Degregorio | NJ | $2.7M | 8.2K | $327.20 |
| 21 | Dalpinder Sandhu | CA | $2.7M | 16.3K | $164.35 |
| 22 | Michael Krueger | CA | $2.7M | 19.9K | $134.73 |
| 23 | David Cusick | IL | $2.6M | 14.4K | $183.06 |
| 24 | Sarabjeet Singh | CA | $2.6M | 31.8K | $82.72 |
| 25 | Russell Fileccia | LA | $2.6M | 12.7K | $200.91 |
| Code | Description | Payments | Services | Avg/Service |
|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | $716.5M | 8.0M | $90.08 |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | $431.8M | 5.0M | $85.69 |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | $187.9M | 918.9K | $204.49 |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | $127.9M | 2.0M | $63.56 |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | $119.6M | 1.2M | $96.34 |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | $117.8M | 896.6K | $131.41 |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | $108.9M | 1.7M | $62.62 |
| 78431 | Nuclear medicine studies of blood flow in heart muscle at rest and with stress with concurrent ct scan | $101.1M | 85.4K | $1.2K |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | $92.4M | 671.9K | $137.51 |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | $89.3M | 770.6K | $115.94 |
| 78492 | Nuclear medicine studies of blood flow in heart muscle at rest and with stress | $77.2M | 71.8K | $1.1K |
| A9555 | Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | $76.5M | 187.0K | $409.33 |
| J2785 | Injection, regadenoson, 0.1 mg | $68.4M | 1.6M | $42.37 |
| 93880 | Ultrasound of both sides of head and neck blood flow | $59.3M | 481.2K | $123.32 |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | $55.2M | 5.1M | $10.77 |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | $51.0M | 498.0K | $102.42 |
| 93229 | Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | $50.0M | 71.6K | $698.95 |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | $47.1M | 7.6M | $6.19 |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | $42.9M | 311.2K | $137.83 |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | $41.8M | 475.5K | $87.88 |
Last Updated: February 2026 (data through 2023, the latest CMS release)
Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.